Tiziana Life Sciences (TLSA) Announces Submission of Patent Application for Nasal Administration of Foralumab for Treatment of COVID-19 Patients

Go back to Tiziana Life Sciences (TLSA) Announces Submission of Patent Application for Nasal Administration of Foralumab for Treatment of COVID-19 Patients
(NASDAQ: TLSA) Delayed: 1.08 --0 (-0%)
Previous Close $1.08    52 Week High
Open $1.08    52 Week Low
Day High $1.08    P/E N/A 
Day Low $1.08    EPS
Volume 1,582